HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis.

AbstractOBJECTIVES:
HCV and NAFLD are associated with atherosclerosis in general population. The prevalence of atherosclerosis in chronic hepatitis C (CHC) patients is unknown. We hypothesized that HCV per se and HCV-related steatosis could favour atherosclerosis. Thus, in CHC patients we assessed: (a) the prevalence of atherosclerosis; (b) the role of HCV, cardio-metabolic risk factors and hepatic histology.
METHODS:
Overall, 803 subjects were enrolled: (A) 326 patients with liver biopsy-proven treatment naive CHC (175 with and 151 without steatosis); (B) 477 age and gender matched controls, including 292 healthy subjects without steatosis (B1) and 185 with NAFLD (B2). Carotid atherosclerosis (CA), assessed by high-resolution B-mode ultrasonography, was categorized as either intima-media thickness (IMT: >1mm) or plaques (≥ 1.5mm).
RESULTS:
CHC patients had a higher prevalence of CA than controls (53.7% vs 34.3%; p<0.0001). Younger CHC (<50 years) had a higher prevalence of CA than controls (34.0% vs 16.0%; p<0.04). CHC patients without steatosis had a higher prevalence of CA than B1 controls (26.0% vs 14.8%; p<0.02). CHC with steatosis had a higher prevalence of CA than NAFLD patients (77.7% vs 57.8%, p<0.0001). Viral load was associated with serum CRP and fibrinogen levels; steatosis with metabolic syndrome, HOMA-IR, hyperhomocysteinemia and liver fibrosis. Viral load and steatosis were independently associated with CA. Diabetes and metabolic syndrome were associated with plaques.
CONCLUSION:
HCV infection is a risk factor for earlier and facilitated occurrence of CA via viral load and steatosis which modulate atherogenic factors such as inflammation and dysmetabolic milieu.
AuthorsLuigi E Adinolfi, Luciano Restivo, Rosa Zampino, Barbara Guerrera, Amedeo Lonardo, Laura Ruggiero, Francesco Riello, Paola Loria, Anna Florio
JournalAtherosclerosis (Atherosclerosis) Vol. 221 Issue 2 Pg. 496-502 (Apr 2012) ISSN: 1879-1484 [Electronic] Ireland
PMID22385985 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012. Published by Elsevier Ireland Ltd.
Topics
  • Adult
  • Age Factors
  • Aged
  • Biopsy
  • Carotid Artery Diseases (diagnostic imaging, epidemiology)
  • Carotid Intima-Media Thickness
  • Case-Control Studies
  • Fatty Liver (diagnosis, epidemiology)
  • Female
  • Hepatitis C, Chronic (diagnosis, epidemiology)
  • Humans
  • Italy (epidemiology)
  • Logistic Models
  • Male
  • Metabolic Syndrome (epidemiology)
  • Middle Aged
  • Multivariate Analysis
  • Non-alcoholic Fatty Liver Disease
  • Plaque, Atherosclerotic (diagnostic imaging, epidemiology)
  • Prevalence
  • Prospective Studies
  • Risk Assessment
  • Risk Factors
  • Viral Load
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: